Key result
Fontan operation in impaired ventricular function is linked to 0% early mortality and maintained EF.
Why the study?
What are the clinical outcomes of the Fontan operation in patients with impaired ventricular function?
Observational (n=29)
What are the clinical outcomes of the Fontan operation in patients with impaired ventricular function?
The Fontan operation can be performed with acceptable intermediate-term clinical outcomes and preserved ventricular function in high-risk patients with pre-existing impaired ventricular function.
May support expanded Fontan candidacy despite impaired function; leaves open need for prospective validation of durability.
OBJECTIVE: Although a staged Fontan strategy allows for an excellent outcome in high-risk patients, an impaired ventricular function remains a significant factor of early/late mortality and morbidity. This study evaluated the clinical outcome of the Fontan operation in patients with impaired ventricular function. METHODS: A retrospective review was performed on 217 patients who had undergone the Fontan operation between 1991 and 2007. RESULTS: Twenty-nine (13%) of the 217 patients had an impaired ventricular function (ejection fraction (EF) <50%). The median age at the time of the operation was 3 (range: 1-31 years) years. There were five adult patients. The ventricular morphology was right in 20 patients (including five hypoplastic left heart syndrome (HLHS)) and others (left and two-ventricle) in nine patients. Heterotaxy syndrome was present in eight patients. Previous surgical interventions included bidirectional Glenn anastomoses in 24, modified Blalock-Taussig shunts in two and pulmonary artery banding in two. The preoperative EF was 43+/-6%. Significant (moderate or severe) atrioventricular valve regurgitation was noted in four patients. The percutaneous oxygen saturation (SpO(2)) was 82+/-5%. The pulmonary artery pressure and pulmonary artery index were 11+/-3 mmHg and 296+/-102 mm(2)m(-2), respectively. All 29 patients underwent the Fontan operation without any early mortality. There were two late mortalities and two re-operations. EF was maintained at 59+/-15% at a median follow-up of 7.5 (range: 1-19) years. The percent normal systemic ventricular end-diastolic volume decreased from 174+/-95% to 124+/-39% (p<0.05). The SpO(2) increased to 92+/-2%. The mean cardiothoracic ratio in chest X-ray and B-type natriuretic peptide were 51% (range: 35-68%) and 22 pgml(-1) (range: 9-382 pgml(-1)), respectively. Three patients developed congestive heart failure, seven had arrhythmia and two developed protein-losing enteropathy. The New York Heart Association (NYHA) class functional class is I in 21 patients, II in five and III in one. CONCLUSIONS: Acceptable clinical outcomes were observed at an intermediate follow-up of the Fontan operation in patients with an impaired ventricular function.
No takes yet. Share an insight, caveat, or question.
Kotani et al. (2009) conducted an observational in Impaired ventricular function (n=29). Fontan operation was evaluated on Early mortality. The Fontan operation in patients with impaired ventricular function resulted in 0% early mortality and maintained ejection fraction at 59% over a median follow-up of 7.5 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: